Company page

Immucell Corporation

Immucell Corporation, trading under the ticker ICCC, is a public company based in the United States with a market capitalization of approximately $91.6 million. The company focuses on developing and commercializing innovative products for the veterinary market. Immucell aims to improve animal health and productivity through its specialized offerings.